Polycystic kidney disease

C Bergmann, LM Guay-Woodford, PC Harris… - Nature reviews Disease …, 2018 - nature.com
Cystic kidneys are common causes of end-stage renal disease, both in children and in
adults. Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive …

Autosomal dominant polycystic kidney disease

E Cornec-Le Gall, A Alam, RD Perrone - The Lancet, 2019 - thelancet.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary
kidney disease and one of the most common causes of end-stage kidney disease. Multiple …

[HTML][HTML] Ketosis ameliorates renal cyst growth in polycystic kidney disease

JA Torres, SL Kruger, C Broderick, T Amarlkhagva… - Cell metabolism, 2019 - cell.com
Mild reduction in food intake was recently shown to slow polycystic kidney disease (PKD)
progression in mouse models, but whether the effect was due to solely reduced calories or …

Metabolism and mitochondria in polycystic kidney disease research and therapy

V Padovano, C Podrini, A Boletta… - Nature Reviews …, 2018 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common,
potentially lethal, monogenic diseases and is caused predominantly by mutations in …

Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model

NM Pastor-Soler, H Li, J Pham… - American Journal …, 2022 - journals.physiology.org
Autosomal dominant polycystic kidney disease (ADPKD), caused by mutations in the
polycystin 1 (PKD1) or polycystin 2 genes, presents with progressive development of kidney …

[HTML][HTML] Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial

S Cukoski, CH Lindemann, S Arjune, P Todorova… - Cell Reports …, 2023 - cell.com
Ketogenic dietary interventions (KDIs) are beneficial in animal models of autosomal-
dominant polycystic kidney disease (ADPKD). KETO-ADPKD, an exploratory, randomized …

Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease

KL Nowak, Z You, B Gitomer… - Journal of the …, 2018 - journals.lww.com
The association of overweight/obesity with disease progression in patients with autosomal
dominant polycystic kidney disease (ADPKD) remains untested. We hypothesized that …

A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease

H Ramalingam, S Kashyap, P Cobo-Stark, A Flaten… - Cell metabolism, 2021 - cell.com
Autosomal dominant polycystic kidney disease (ADPKD) is a common monogenic disorder
marked by numerous progressively enlarging kidney cysts. Mettl3, a methyltransferase that …

Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease

LF Menezes, CC Lin, F Zhou, GG Germino - EBioMedicine, 2016 - thelancet.com
Background The major gene mutated in autosomal dominant polycystic kidney disease was
first identified over 20years ago, yet its function remains poorly understood. We have used a …

Recent advances in the management of autosomal dominant polycystic kidney disease

FT Chebib, VE Torres - Clinical Journal of the American Society of …, 2018 - journals.lww.com
Autosomal dominant polycystic kidney disease (ADPKD), the most common monogenic
cause of ESKD, is characterized by relentless development of kidney cysts, hypertension …